Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,377 Results (Page 17 of 119)
- Relevance
  Sort by

Head and Neck Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4188EUR$4,750USD£3,639GBP

Organ Transplant Immunosuppressant Drugs Market - Global Forecast 2026-2032

 Report
January 2026
195 Pages
Global

From

€3125EUR$3,545USD£2,716GBP

€3473EUR$3,939USD£3,018GBP

CD137 Antibodies Clinical Trials & Market Opportunity Insight

 Report
September 2024
210 Pages
Global

From

€2116EUR$2,400USD£1,839GBP

Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028

 Report
August 2024
195 Pages
Global

From

€2116EUR$2,400USD£1,839GBP

US Urinary Tract Infection Therapeutics outlook to 2028

 Report
August 2023
85 Pages
United States

From

€4276EUR$4,850USD£3,716GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Atopic Dermatitis Drugs - Global Strategic Business Report

 Report
April 2026
179 Pages
Global

From

€5158EUR$5,850USD£4,482GBP

Vitiligo Therapeutics - Global Strategic Business Report

 Report
April 2026
192 Pages
Global

From

€5158EUR$5,850USD£4,482GBP

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA

 Report
December 2025
123 Pages
United States

From

€2200EUR$2,495USD£1,912GBP

Rnai Drug Delivery Market 2024-2028

 Report
July 2024
180 Pages
Global

From

€2204EUR$2,500USD£1,915GBP

Pharmaceutical Elixir Market Insights, Competitive Landscape, and Market Forecast - 2033

 Report
March 2026
191 Pages
Global

From

€4404EUR$4,995USD£3,827GBP

Generic Musculoskeletal Disorders Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3959EUR$4,490USD£3,440GBP

Non-small Cell Lung Cancer Drugs Market 2023-2027

 Report
May 2023
167 Pages
Global

From

€2204EUR$2,500USD£1,915GBP

Psoriasis Drugs Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3125EUR$3,545USD£2,716GBP

€3473EUR$3,939USD£3,018GBP

Anxiety and Panic Disorders Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
86 Pages
Global

From

€3500EUR$4,253USD£3,148GBP

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
321 Pages
Global

€4404EUR$4,995USD£3,827GBP

Psoriasis Treatment Market - Global Forecast 2025-2032

 Report
November 2025
181 Pages
Global

From

€3125EUR$3,545USD£2,716GBP

€3473EUR$3,939USD£3,018GBP

Beta Lactam & Beta Lactamase Inhibitors Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3125EUR$3,545USD£2,716GBP

€3473EUR$3,939USD£3,018GBP

Ovarian Cancer Diagnostics and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4188EUR$4,750USD£3,639GBP

Europe Ovarian Cancer Diagnostics and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
75 Pages
Europe

From

€4188EUR$4,750USD£3,639GBP

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report

 Report
April 2026
220 Pages
Global

From

€5158EUR$5,850USD£4,482GBP

2,377 Results (Page 17 of 119)
- 1
- 15
- 16
- 17
- 18
- 19

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.